<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1470-7330-14-S1-O27</article-id><article-id pub-id-type="doi">10.1186/1470-7330-14-S1-O27</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral Presentation</subject></subj-group></article-categories><title-group><article-title>Noncommunicating cystic pancreatic lesions (i.e. serous and mucinous cystadenoma + rare lesions)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Heiken</surname><given-names>Jay P</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2014</year></pub-date><volume>14</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.</named-content></supplement><fpage>O27</fpage><lpage>O27</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Heiken; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Heiken; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/14/S1/O27"/><conference><conf-date>9-11 October 2014</conf-date><conf-name>International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</conf-name><conf-loc>Heidelberg, Germany</conf-loc></conference></article-meta></front><body><sec><title/><p><italic>Mucinous cystic neoplasm (MCN)</italic> occurs predominantly in women (&#x0003e;95%) with a mean age of approximately 45 years and most commonly is located in the pancreatic body or tail. The mass is lined by mucin-producing columnar epithelium with a fibrous ovarian-type stroma. The epithelial lining can contain various degrees of atypia, ranging from adenoma to invasive carcinoma. The CT and MR appearance is that of a thick walled cystic mass with septa and/or mural nodules. The contour of the mass is smooth, and the wall or septa may contain calcification. Endoscopic ultrasound with fine needle aspiration of the cyst fluid to assess CEA level may be helpful in distinguishing MCN from serous cystadenoma. CEA &#x0003c;5 ng/mL favors serous cystadenoma, whereas CEA &#x0003e;192 ng/mL favors MCN, with an accuracy of approximately 80% [<xref ref-type="bibr" rid="B1">1</xref>]. The overall risk of malignancy in one series was 17.5%, and all malignant tumors were either &#x0003e;4 cm or contained mural nodules [<xref ref-type="bibr" rid="B2">2</xref>]. Treatment of MCN is surgical resection, and patients without extracapsular or diffuse intracapsular infiltration have an excellent prognosis [<xref ref-type="bibr" rid="B2">2</xref>].</p><p><italic>Serous cystadenoma (SCA)</italic> also occurs predominantly in women (approximately 75%), but the mean age is older (mid 50s to early 60s). It is lined by glycogen-rich cuboidal epithelium and is considered a benign neoplasm, although rare cases of malignant SCA have been reported. The typical appearance is that of a lobulated mass consisting of numerous tiny cysts which give it a honeycomb appearance. Larger lesions may contain a central stellate scar and calcifications. Oligocystic or macrocystic SCA is an uncommon variant comprised of a small number of larger cysts. Distinction between macrocystic SCA and MCN can be made based on the lobulated contour of SCA, its multiple clustered cyst configuration and homogeneity of each locule on T1 weighted MR images [<xref ref-type="bibr" rid="B3">3</xref>]. Surgical resection generally is reserved for symptomatic patients, although some authors recommend periodic imaging to assess the rate of growth, with consideration given to surgical resection of lesions with doubling time of &#x0003c;6 years [<xref ref-type="bibr" rid="B4">4</xref>].</p><p><italic>Solid pseudopapillary neoplasm (SPN)</italic> is a rare low-grade malignancy that predominantly affects younger women (&#x0003e;80%), with a median age 30-38 years [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. It is not a true cystic neoplasm in that the cystic component lacks an epithelial lining. Rather, the cystic component represents necrotic degeneration of the mass, with various amounts of internal blood and debris. SPN appears as a well-circumscribed round or oval thick-walled mass with solid and cystic components, but it can appear completely solid or completely cystic. CT demonstrates calcification in nearly half of SPNs [<xref ref-type="bibr" rid="B6">6</xref>]. MR often demonstrates a thick T2 hypointense or enhancing rim and internal blood products. Treatment is surgical resection, and the prognosis is excellent, with metastases developing in &#x0003c;5% of patients [<xref ref-type="bibr" rid="B6">6</xref>].</p><p><italic>Cystic neuroendocrine neoplasm</italic> of the pancreas most commonly occurs in patients with multiple endocrine neoplasia type I and usually is nonfunctional [<xref ref-type="bibr" rid="B7">7</xref>]. It generally appears as a cystic mass with an enhancing rim and may contain septa or a solid component. Treatment usually is surgical resection, although observation may be a viable alternative approach [<xref ref-type="bibr" rid="B8">8</xref>].</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Brugge</surname><given-names>WR</given-names></name><name><surname>Lewandrowski</surname><given-names>K</given-names></name><name><surname>Lee-Lewandrowski</surname><given-names>E</given-names></name><etal/><article-title>Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study</article-title><source>Gastroenterology</source><year>2004</year><volume>126</volume><fpage>1330</fpage><lpage>1336</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2004.02.013</pub-id><?supplied-pmid 15131794?><pub-id pub-id-type="pmid">15131794</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Crippa</surname><given-names>S</given-names></name><name><surname>Salvia</surname><given-names>R</given-names></name><name><surname>Warshaw</surname><given-names>AL</given-names></name><etal/><article-title>Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients</article-title><source>Ann Surg</source><year>2008</year><volume>247</volume><fpage>571</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1097/SLA.0b013e31811f4449</pub-id><?supplied-pmid 18362619?><pub-id pub-id-type="pmid">18362619</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><etal/><article-title>MRI features of serous oligocystic adenoma of the pancreas: differentiation from mucinous cystic neoplasm of the pancreas</article-title><source>British J Radiol</source><year>2012</year><volume>85</volume><fpage>571</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1259/bjr/42007785</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>El-Hayek</surname><given-names>KM</given-names></name><name><surname>Brown</surname><given-names>N</given-names></name><name><surname>O&#x02019;Rourke</surname><given-names>C</given-names></name><etal/><article-title>Rate of growth of pancreatic serous cystadenoma as an indicator for resection</article-title><source>Surgery</source><year>2013</year><volume>154</volume><fpage>794</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2013.07.005</pub-id><?supplied-pmid 24074417?><pub-id pub-id-type="pmid">24074417</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Butte</surname><given-names>JM</given-names></name><name><surname>Brennan</surname><given-names>MF</given-names></name><name><surname>G&#x000f6;nen</surname><given-names>M</given-names></name><etal/><article-title>Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center</article-title><source>J Gastrointest Surg</source><year>2011</year><volume>15</volume><fpage>350</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1007/s11605-010-1337-1</pub-id><?supplied-pmid 20824369?><pub-id pub-id-type="pmid">20824369</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Raman</surname><given-names>SP</given-names></name><name><surname>Kawamoto</surname><given-names>S</given-names></name><name><surname>Law</surname><given-names>JK</given-names></name><etal/><article-title>Institutional experience with solid pseudopapillary neoplasms: focus on computed tomography, magnetic resonance imaging, conventional ultrasound, endoscopic ultrasound, and predictors of aggressive histology</article-title><source>J Comput Assist Tomogr</source><year>2013</year><volume>37</volume><fpage>824</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1097/RCT.0b013e31829d44fa</pub-id><?supplied-pmid 24045264?><pub-id pub-id-type="pmid">24045264</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Bordeianou</surname><given-names>L</given-names></name><name><surname>Vaqefi</surname><given-names>PA</given-names></name><name><surname>Sahani</surname><given-names>D</given-names></name><etal/><article-title>Cystic pancreatic endocrine neoplasms: a distinct tumor type?</article-title><source>J Am Coll Surg</source><year>2008</year><volume>206</volume><fpage>1154</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2007.12.040</pub-id><?supplied-pmid 18501813?><pub-id pub-id-type="pmid">18501813</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>LC</given-names></name><name><surname>Grant</surname><given-names>CS</given-names></name><name><surname>Salomao</surname><given-names>DR</given-names></name><etal/><article-title>Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management</article-title><source>Surgery</source><year>2012</year><volume>152</volume><fpage>965</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2012.08.038</pub-id><?supplied-pmid 23102679?><pub-id pub-id-type="pmid">23102679</pub-id></mixed-citation></ref></ref-list></back></article>
